Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
CAPR.OQ - Capricor Therapeutics Inc
Capricor Therapeutics Inc at Goldman Sachs Healthcare Conference
Jun 10, 2026 / 02:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Of Biotech Investment Banking. I'm thrilled today to welcome Linda Marvin, CEO of Capricor, and AJ Bergen, CFO of Capricor.
As a quick background on Linda and AJ, as well as Capricor, Linda is co-founder of Capricor, has served as CEO since 2010.
Linda has been in the biotech field for over 20 years, and prior to Capricor, held various senior roles at Exigen, a genome therapy biotech company.
AJ has served as Capricor's CFO since 2018 and has been in the biotech industry for 15 years, joined the company in 2011.
Capricor is a late-stage biotech company developing dera male cell, an allogeneic cardiac-derived cell therapy that has filed for approval for treatment of
Trustpilot
